首页> 美国卫生研究院文献>other >Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon
【2h】

Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon

机译:与在喀麦隆进行的Abbott RealTime HIV-1相比用于HIV-1病毒载量监测的开放式多价通用HIV-1 / SIVcpz / SIVgor定量RT-PCR检测方法的现场评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

With the increasing demand of HIV viral load (VL) tests in resource-limited countries (RLCs) there is a need for assays at affordable cost and able to quantify all known HIV-1 variants. VLs obtained with a recently developed open and polyvalent universal HIV-1/SIVcpz/SIVgor RT-qPCR were compared to Abbott RealTime HIV-1 assay in Cameroon. On 474 plasma samples, characterized by a wide range of VLs and a broad HIV-1 group M genetic diversity, 97.5% concordance was observed when using the lower detection limit of each assay. When using the threshold of 3.00 log10 copies/mL, according to WHO guidelines to define virological failure (VF) in RLCs, the concordance was 94.7%, 360/474 versus 339/474 patients were identified with VF with the new assay and Abbott RealTime HIV-1, respectively. Higher VLs were measured with the new assay, +0.47 log10 copies/mL (95% CI; 0.42-0.52) as shown with Bland-Altman analysis. Eleven samples from patients on VF with drug resistance were not detected by Abbott RealTime HIV-1 versus two only with the new assay. Overall, our study showed that the new assay can be easily implemented in a laboratory in RLCs with VL experience and showed good performance on a wide diversity of HIV-1 group M variants.
机译:在资源有限的国家(RLC)中,随着对HIV病毒载量(VL)检测的需求不断增加,需要以可承受的成本进行检测并能够量化所有已知HIV-1变体的检测方法。使用最近开发的开放式多价通用HIV-1 / SIVcpz / SIVgor RT-qPCR获得的VLs与喀麦隆的Abbott RealTime HIV-1测定法进行了比较。在474个血浆样品中,其特征在于广泛的VL和广泛的HIV-1 M组遗传多样性,当使用每种测定法的下限检测时,观察到97.5%的一致性。当使用3.00 log10拷贝/ mL的阈值时,根据WHO指南定义RLC中的病毒学衰竭(VF),一致性为94.7%,通过新测定法和Abbott RealTime将VF鉴定为360/474与339/474患者HIV-1。如Bland-Altman分析所示,使用新测定法测得的较高VLs为+0.47 log10拷贝/ mL(95%CI; 0.42-0.52)。雅培RealTime HIV-1未检测到11例患有VF耐药药物的患者,而新方法仅检测了2例。总的来说,我们的研究表明,这种新方法可以在具有VL经验的RLC中轻松地在实验室中实施,并且对多种HIV-1 M组变异株表现出良好的性能。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号